Cancer-associated thrombosis and palliative care: an interview with Simon Noble. (January 2017)

• Record Type: Journal Article
• Authors: Noble, Simon
• Is Part Of: Future oncology. Volume 13:Number 1(2017)
• Page Start: 13
• Page End: 17
• Publication Date: 2017-01
• Subjects: anticoagulation -- blood clots cancer and you -- cancer-associated thrombosis -- CAT -- heparins -- palliative care -- patient experience -- PELICAN -- thromboprophylaxis -- thrombosis -- venous thromboembolism; Oncology -- Periodicals; 616.99405
• DOI: 10.2217/fon-2016-0435
• Languages: English
• ISSNs: 1479-6694

Abstract

Simon Noble speaks to Sebastian Dennis-Beron, Commissioning Editor: Simon Noble is Clinical Professor in Palliative Medicine at Cardiff University and honorary consultant at the Royal Gwent Hospital in Newport. His main research interests are in the management of venous thromboembolism in advanced cancer, quality of life effects of venous thromboembolism and their therapies, clinical decision-making in venous thromboembolism management and the patient journey. He is involved at a national level in the delivery of evidence-based thromboprophylaxis for hospitalized patients through the All Party Thrombosis Group and sits on the NICE Guideline development group for thromboprophylaxis. He is a Medical Director of Thrombosis UK and is currently chairing the All Wales HAT Prevention Steering Group. Internationally he sits on the ISTH Cancer Scientific Sub Committee and American Society for Hematology Cancer Associated Thrombosis Guidelines. He has published over 100 original papers.